skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 4
Patent #:
8492588
Issue Dt:
07/23/2013
Application #:
13483018
Filing Dt:
05/29/2012
Publication #:
20120329869
Pub Dt:
12/27/2012
Inventors:
Jim Zhen Wu, Jean-Michel Vemier, Huanming Chen, Jianlan Song
Title:
BENZYLOXY ANILIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS
Assignment: 1
Reel/Frame:
039380/0385Recorded: 07/18/2016Pages: 21
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
07/18/2016
BAUSCH & LOMB INCORPORATED
Exec Dt:
07/18/2016
BAUSH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
07/18/2016
DENDREON PHARMACEUTICALS, INC.
Exec Dt:
07/18/2016
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
07/18/2016
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
07/18/2016
OBAGI MEDICAL PRODUCTS, INC.
Exec Dt:
07/18/2016
OMP, INC.
Exec Dt:
07/18/2016
ORAPHARMA, INC.
Exec Dt:
07/18/2016
PRECISION DERMATOLOGY, INC.
Exec Dt:
07/18/2016
SALIX PHARMACEUTICALS, INC.
Exec Dt:
07/18/2016
SALIX PHARMACEUTICALS, LTD
Exec Dt:
07/18/2016
SANTARUS, INC.
Exec Dt:
07/18/2016
SOLTA MEDICAL, INC.
Exec Dt:
07/18/2016
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
07/18/2016
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA)
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
07/18/2016
VALEANT PHARMACEUTICALS IRELAND
Exec Dt:
07/18/2016
Assignee:
BARCLAYS BANK PLC
745 SEVENTH AVENUE
27TH FLOOR
NEW YORK, NEW YORK 10019
Correspondent:
SKADDEN, ARPS, SLATE, MEAGHER & FLOM
FOUR TIMES SQUARE
MONIQUE L. RIBANDO
NEW YORK, NY 10036
Assignment: 2
Reel/Frame:
043045/0913Recorded: 07/19/2017Pages: 10
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
07/17/2017
Assignee:
THE BANK OF NEW YORK MELLON
101 BARCLAY STREET
FLOOR 7E
NEW YORK, NEW YORK 10286
Correspondent:
STEWART WALSH
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 3
Reel/Frame:
045444/0299Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE
NEW YORK, NEW YORK 10019
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005
Assignment: 4
Reel/Frame:
045444/0634Recorded: 02/26/2018Pages: 69
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ATON PHARMA, INC.
Exec Dt:
02/13/2018
BAUSCH & LOMB INCORPORATED
Exec Dt:
02/13/2018
BAUSCH & LOMB PHARMA HOLDINGS CORP.
Exec Dt:
02/13/2018
COMMONWEALTH LABORATORIES, LLC
Exec Dt:
02/13/2018
DOW PHARMACEUTICAL SCIENCES, INC.
Exec Dt:
02/13/2018
ECR PHARMACEUTICALS CO., INC.
Exec Dt:
02/13/2018
LABORATOIRE CHAUVIN S.A.S.
Exec Dt:
02/13/2018
MEDICIS PHARMACEUTICAL CORPORATION
Exec Dt:
02/13/2018
ONPHARMA INC.
Exec Dt:
02/13/2018
ORAPHARMA, INC.
Exec Dt:
02/13/2018
PRECISION DERMATOLOGY, INC.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
02/13/2018
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/13/2018
SANTARUS, INC.
Exec Dt:
02/13/2018
SOLTA MEDICAL, INC.
Exec Dt:
02/13/2018
SYNERGETICS USA, INC.
Exec Dt:
02/13/2018
TECHNOLAS PERFECT VISION GMBH
Exec Dt:
02/13/2018
VALEANT CANADA LP
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Exec Dt:
02/13/2018
WIRRA IP PTY LIMITED
Exec Dt:
02/13/2018
VALEANT PHARMA POLAND SP. Z O.O.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
Exec Dt:
02/13/2018
VALEANT PHARMACEUTICALS IRELAND LIMITED
Exec Dt:
02/13/2018
Assignee:
THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
101 BARCLAY STREET
FLOOR 7E
NEW YORK, NEW YORK 10286
Correspondent:
MELONY SOT
1025 VERMONT AVE NW, SUITE 1130
COGENCY GLOBAL INC.
WASHINGTON, DC 20005

Search Results as of: 05/04/2024 04:25 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT